Less is More

Less is More

Share this article

  • Johnson & Johnson announced its plan to reduce its stake in Kenvue, the consumer health business it spun out earlier this year, by at least 80%. The reduction will be achieved through a stock exchange offer, where J&J shareholders can swap their shares for Kenvue's common stock at a 7% discount.
  • J&J currently owns 89.6% of Kenvue's common stock, totaling over 1.72 billion shares. The exchange offer is expected to be tax-free and voluntary for investors, with the closing date set for August 18, which is earlier than originally anticipated.

Why it matters

  • The significance of this news lies in Johnson & Johnson's decision to reduce its stake significantly in Kenvue. By offering J&J shareholders the opportunity to exchange their shares, the company aims to further separate its consumer health business and allow investors to become more directly involved in Kenvue's future.

Get Smarter
About Investing

Join 35,000+ subscribers and get our 5 min daily newsletter on daily local and international financial news.
Get Smarter<br/> About Investing

Similar News